Brent Saunders keeps rolling out the changes at Bausch + Lomb; Incyte CSO to exit next month

Asli Gevgilili

Bausch + Lomb CEO Brent Saunders told Andrew Dunn on Wednesday that he’d take time to “digest” the $1.75 billion deal he made for Xiidra “but will continue to look to source smaller deals.” Meanwhile, Saunders isn’t dealing in small leadership…
Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks